David P. Ryan, M.D.
Board Member
Cullinan Therapeutics, Inc. (CGEM)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David P. Ryan, M.D.
David P. Ryan, M.D. is recorded as Board Member at Cullinan Therapeutics, Inc. (CGEM). Cullinan Therapeutics, Inc. reported in an 8-K filed November 2, 2022 that David P. Ryan, M.D. was appointed Class II director, effective November 1, 2022.
“On November 1, 2022, the Board of Directors (the "Board") of Cullinan Oncology, Inc. (the "Company") appointed David P. Ryan, M.D. as a Class II director, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-11-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cullinan Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Nadim Ahmed CEO, Board Member
- Owen Hughes CEO
- Mary Kay Fenton CFO, Chief Accounting Officer, Board Member
- Andrew Allen Board Member
- Andrew Allen, M.D., Ph.D. Board Member
- Anne-Marie Martin, Ph.D. Board Member
- Corinne Savill Board Member
- Jacquelyn Sumer Board Member
- Jeffrey Jones Board Member
- Jennifer Michaelson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.